Dendritic cells adhere to and transmigrate across lymphatic endothelium in response to IFN-α

European Journal of Immunology

Volumn 40, Issue 11, 2010, Pages 3054-3063

  Rouzaut, Ana ^a   Garasa, Saray ^a   Teijeira, Álvaro ^a,b   González, Iranzu ^a   Martinez Forero, Ivan ^a   Suarez, Natalia ^c   Larrea, Esther ^a   Alfaro, Carlos ^a,c   Palazón, Asís ^a   Dubrot, Juan ^a   Hervás Stubbs, Sandra ^a   Melero, Ignacio ^a,c  

^a UNIVERSITY OF NAVARRA   (Spain)

^b UNIVERSITY OF NAVARRA   (Spain)

^c UNIVERSITY CLINIC OF NAVARRA   (Spain)

Author keywords

Cell traffic; DC; Inflammation; Integrins; Lymphatic vessels

Indexed keywords

ALPHA INTERFERON; ALPHA2B INTERFERON; ALPHA5 INTERFERON; INTERLEUKIN 4; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; UNCLASSIFIED DRUG; VERY LATE ACTIVATION ANTIGEN 4; ALPHA INTERFERON 5; ALPHA2 INTERFERON; INTERFERON-ALPHA 2; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; CELL ADHESION; CELL CULTURE; CELL DIFFERENTIATION; CONTROLLED STUDY; DENDRITIC CELL; FEMALE; HUMAN; HUMAN CELL; IN VIVO STUDY; INFLAMMATION; LYMPH VESSEL ENDOTHELIUM; MONOLAYER CULTURE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; TRANSCELLULAR CELL MIGRATION; ANIMAL; CELL MOTION; COCULTURE; DRUG EFFECT; IMMUNOLOGY;

ANIMALS; ANTIGENS, CD11A; CELL ADHESION; CELL DIFFERENTIATION; CELL MOVEMENT; COCULTURE TECHNIQUES; DENDRITIC CELLS; ENDOTHELIUM, LYMPHATIC; HUMANS; INTERFERON-ALPHA; LYMPHOCYTE FUNCTION-ASSOCIATED ANTIGEN-1; MICE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 79952109911     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201040523     Document Type: Article

References (53)

1. Johnson, L. A. and Jackson, D. G., Cell traffic and the lymphatic endothelium. Ann. NY Acad. Sci. 2008. 1131: 119-133.
2. Karpanen, T. and Alitalo, K., Molecular biology and pathology of lymphangiogenesis. Annu. Rev. Pathol. 2008. 3: 367-397.
3. Oliver, G. and Srinivasan, R. S., Lymphatic vasculature development: current concepts. Ann. NY Acad. Sci. 2008. 1131: 75-81.
4. Randolph, G. J., Angeli, V. and Swartz, M. A., Dendritic-cell trafficking to lymph nodes through lymphatic vessels. Nat. Rev. Immunol. 2005. 5: 617-628.
5. Forster, R., Davalos-Misslitz, A. C. and Rot, A., CCR7 and its ligands: balancing immunity and tolerance. Nat. Rev. Immunol. 2008. 8: 362-371.
6. Mackay, C. R., Marston, W. L. and Dudler, L., Naive and memory T cells show distinct pathways of lymphocyte recirculation. J. Exp. Med. 1990. 171: 801-817.
7. MartIn-Fontecha, A., Sebastiani, S., Hopken, U. E., Uguccioni, M., Lipp, M., Lanzavecchia, A. and Sallusto, F., Regulation of dendritic cell migration to the draining lymph node: impact on T lymphocyte traffic and priming. J. Exp. Med. 2003. 198: 615-621.
8. Alvarez, D., Vollmann, E. H. and von Andrian, U. H., Mechanisms and consequences of dendritic cell migration. Immunity 2008. 29: 325-342.
9. Burton, J. B., Priceman, S. J., Sung, J. L., Brakenhielm, E., An, D. S., Pytowski, B., Alitalo, K. and Wu, L., Suppression of prostate cancer nodal and systemic metastasis by blockade of the lymphangiogenic axis. Cancer Res. 2008. 68: 7828-7837.
10. Springer, T. A., Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell 1994. 76: 301-314.
11. Cambi, A., Joosten, B., Koopman, M., de Lange, F., Beeren, I., Torensma, R., Fransen, J. A. et al., Organization of the integrin LFA-1 in nanoclusters regulates its activity. Mol. Biol. Cell 2006. 17: 4270-4281.
12. Arroyo, A. G., Sanchez-Mateos, P., Campanero, M. R., Martin-Padura, I., Dejana, E. and Sanchez-Madrid, F., Regulation of the VLA integrin-ligand interactions through the beta 1 subunit. J. Cell. Biol. 1992. 117: 659-670.
13. Hogg, N., Harvey, J., Cabanas, C. and Landis, R. C., Control of leukocyte integrin activation. Am. Rev. Respir. Dis. 1993. 148: S55-S59.
14. Pflicke, H. and Sixt, M., Preformed portals facilitate dendritic cell entry into afferent lymphatic vessels. J. Exp. Med. 2009. 206: 2925-2935.
15. Enk, A. H., Angeloni, V. L., Udey, M. C. and Katz, S. I., An essential role for Langerhans cell-derived IL-1 beta in the initiation of primary immune responses in skin. J. Immunol. 1993. 150: 3698-3704.
16. Wang, B., Fujisawa, H., Zhuang, L., Kondo, S., Shivji, G. M., Kim, C. S., Mak, T. W. and Sauder, D. N., Depressed Langerhans cell migration and reduced contact hypersensitivity response in mice lacking TNF receptor p75. J. Immunol. 1997. 159: 6148-6155.
17. Gallucci, S., Lolkema, M. and Matzinger, P., Natural adjuvants: endogenous activators of dendritic cells. Nat. Med. 1999. 5: 1249-1255.
18. Sallusto, F., Schaerli, P., Loetscher, P., Schaniel, C., Lenig, D., Mackay, C. R., Qin, S. and Lanzavecchia, A., Rapid and coordinated switch in chemokine receptor expression during dendritic cell maturation. Eur. J. Immunol. 1998. 28: 2760-2769.
19. Podgrabinska, S., Kamalu, O., Mayer, L., Shimaoka, M., Snoeck, H., Randolph, G. J. and Skobe, M., Inflamed lymphatic endothelium suppresses dendritic cell maturation and function via Mac-1/ICAM-1-dependent mechanism. J. Immunol. 2009. 183: 1767-1779.
20. Johnson, L. A., Clasper, S., Holt, A. P., Lalor, P. F., Baban, D. and Jackson, D. G., An inflammation-induced mechanism for leukocyte transmigration across lymphatic vessel endothelium. J. Exp. Med. 2006. 203: 2763-2777.
21. Nair, S., McLaughlin, C., Weizer, A., Su, Z., Boczkowski, D., Dannull, J., Vieweg, J. and Gilboa, E., Injection of immature dendritic cells into adjuvant-treated skin obviates the need for ex vivo maturation. J. Immunol. 2003. 171: 6275-6282.
22. Platanias, L. C., Mechanisms of type-I- and type-II-interferon-mediated signalling. Nat. Rev. Immunol. 2005. 5: 375-386.
23. Sadler, A. J. and Williams, B. R., Interferon-inducible antiviral effectors. Nat. Rev. Immunol. 2008. 8: 559-568.
24. Le Bon, A., Etchart, N., Rossmann, C., Ashton, M., Hou, S., Gewert, D., Borrow, P. and Tough, D. F., Cross-priming of CD8+ T cells stimulated by virus-induced type I interferon. Nat. Immunol. 2003. 4: 1009-1015.
25. Le Bon, A. and Tough, D. F., Type I interferon as a stimulus for crosspriming. Cytokine Growth Factor Rev. 2008. 19: 33-40.
26. Parlato, S., Santini, S. M., Lapenta, C., Di Pucchio, T., Logozzi, M., Spada, M., Giammarioli, A. M. et al., Expression of CCR-7, MIP-3beta, and Th-1 chemokines in type I IFN-induced monocyte-derived dendritic cells: importance for the rapid acquisition of potent migratory and functional activities. Blood 2001. 98: 3022-3029.
27. Curtsinger, J. M., Valenzuela, J. O., Agarwal, P., Lins, D. and Mescher, M. F., Type I IFNs provide a third signal to CD8 T cells to stimulate clonal expansion and differentiation. J. Immunol. 2005. 174: 4465-4469.
28. Mailliard, R. B., Wankowicz-Kalinska, A., Cai, Q., Wesa, A., Hilkens, C. M., Kapsenberg, M. L., Kirkwood, J. M. et al., alpha-type-1 polarized dendritic cells: a novel immunization tool with optimized CTL-inducing activity. Cancer Res. 2004. 64: 5934-5937.
29. Gautier, G., Humbert, M., Deauvieau, F., Scuiller, M., Hiscott, J., Bates, E. E., Trinchieri, G. et al., A type I interferon autocrine-paracrine loop is involved in Toll-like receptor-induced interleukin-12p70 secretion by dendritic cells. J. Exp. Med. 2005. 201: 1435-1446.
30. Santodonato, L., D'Agostino, G., Nisini, R., Mariotti, S., Monque, D. M., Spada, M., Lattanzi, L. et al., Monocyte-derived dendritic cells generated after a short-term culture with IFN-alpha and granulocyte-macrophage colony-stimulating factor stimulate a potent Epstein-Barr virus-specific CD8+ T cell response. J. Immunol. 2003. 170: 5195-5202.
31. Santini, S. M., Di Pucchio, T., Lapenta, C., Parlato, S., Logozzi, M. and Belardelli, F., A new type I IFN-mediated pathway for the rapid differentiation of monocytes into highly active dendritic cells. Stem Cells 2003. 21: 357-362.
32. Barreiro, O., de la Fuente, H., Mittelbrunn, M. and Sanchez-Madrid, F., Functional insights on the polarized redistribution of leukocyte integrins and their ligands during leukocyte migration and immune interactions. Immunol. Rev. 2007. 218: 147-164.
33. Ma, J., Wang, J. H., Guo, Y. J., Sy, M. S. and Bigby, M., In vivo treatment with anti-ICAM-1 and anti-LFA-1 antibodies inhibits contact sensitization-induced migration of epidermal Langerhans cells to regional lymph nodes. Cell. Immunol. 1994. 158: 389-399.
34. Lammermann, T., Bader, B. L., Monkley, S. J., Worbs, T., Wedlich-Soldner, R., Hirsch, K., Keller, M. et al., Rapid leukocyte migration by integrin-independent flowing and squeezing. Nature 2008. 453: 51-55.
35. Dougherty, G. J., Dransfield, I. and Hogg, N., Identification of a novel monocyte cell surface molecule involved in the generation of antigen-induced proliferative responses. Eur. J. Immunol. 1988. 18: 2067-2071.
36. Cabanas, C. and Hogg, N., Ligand intercellular adhesion molecule 1 has a necessary role in activation of integrin lymphocyte function-associated molecule 1. Proc. Natl. Acad. Sci. USA 1993. 90: 5838-5842.
37. Luther, S. A., Tang, H. L., Hyman, P. L., Farr, A. G. and Cyster, J. G., Coexpression of the chemokines ELC and SLC by T zone stromal cells and deletion of the ELC gene in the plt/plt mouse. Proc. Natl. Acad. Sci. USA 2000. 97: 12694-12699.
38. Mori, S., Nakano, H., Aritomi, K., Wang, C. R., Gunn, M. D. and Kakiuchi, T., Mice lacking expression of the chemokines CCL21-ser and CCL19 (plt mice) demonstrate delayed but enhanced T cell immune responses. J. Exp. Med. 2001. 193: 207-218.
39. Jakubzick, C., Bogunovic, M., Bonito, A. J., Kuan, E. L., Merad, M. and Randolph, G. J., Lymph-migrating, tissue-derived dendritic cells are minor constituents within steady-state lymph nodes. J. Exp. Med. 2008. 205: 2839-2850
40. Lapenta, C., Santini, S. M., Logozzi, M., Spada, M., Andreotti, M., Di Pucchio, T., Parlato, S. and Belardelli, F., Potent immune response against HIV-1 and protection from virus challenge in hu-PBL-SCID mice immunized with inactivated virus-pulsed dendritic cells generated in the presence of IFN-alpha. J. Exp. Med. 2003. 198: 361-367.
41. Lopez-Bravo, M. and Ardavin, C., In vivo induction of immune responses to pathogens by conventional dendritic cells. Immunity 2008. 29: 343-351.
42. Montoya, M., Schiavoni, G., Mattei, F., Gresser, I., Belardelli, F., Borrow, P. and Tough, D. F., Type I interferons produced by dendritic cells promote their phenotypic and functional activation. Blood 2002. 99: 3263-3271.
43. Takeda, K., Kaisho, T. and Akira, S., Toll-like receptors. Annu. Rev. Immunol. 2003. 21: 335-376.
44. Schumann, K., Lammermann, T., Bruckner, M., Legler, D. F., Polleux, J., Spatz, J. P., Schuler, G. et al., Immobilized chemokine fields and soluble chemokine gradients cooperatively shape migration patterns of dendritic cells. Immunity 2010. 32: 590-592.
45. Melief, C. J., Cancer immunotherapy by dendritic cells. Immunity 2008. 29: 372-383.
46. Palucka, A. K., Ueno, H., Fay, J. W. and Banchereau, J., Taming cancer by inducing immunity via dendritic cells. Immunol. Rev. 2007. 220: 129-150.
47. de Vries, I. J., Lesterhuis, W. J., Barentsz, J. O., Verdijk, P., van Krieken, J. H., Boerman, O. C., Oyen, W. J. et al., Magnetic resonance tracking of dendritic cells in melanoma patients for monitoring of cellular therapy. Nat. Biotechnol. 2005. 23: 1407-1413.
48. Bracci, L., La Sorsa, V., Belardelli, F. and Proietti, E., Type I interferons as vaccine adjuvants against infectious diseases and cancer. Expert Rev. Vaccines 2008. 7: 373-381.
49. Sangro, B., Melero, I., Qian, C. and Prieto, J., Gene therapy of cancer based on interleukin 12. Curr. Gene Ther. 2005. 5: 573-581.
50. Irigoyen, M., Anso, E., Martinez, E., Garayoa, M., Martinez-Irujo, J. J. and Rouzaut, A., Hypoxia alters the adhesive properties of lymphatic endothelial cells. A transcriptional and functional study. Biochim. Biophys. Acta 2007. 1773: 880-890.
51. Meyer, T. P., Zehnter, I., Hofmann, B., Zaisserer, J., Burkhart, J., Rapp, S., Weinauer, F. et al., Filter Buffy Coats (FBC): a source of peripheral blood leukocytes recovered from leukocyte depletion filters. J. Immunol. Methods 2005. 307: 150-166.
52. Sallusto, F. and Lanzavecchia, A., Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and down-regulated by tumor necrosis factor alpha. J. Exp. Med. 1994. 179: 1109-1118.
53. Tirapu, I., Arina, A., Mazzolini, G., Duarte, M., Alfaro, C., Feijoo, E., Qian, C. et al., Improving efficacy of interleukin-12-transfected dendritic cells injected into murine colon cancer with anti-CD137 monoclonal anti-bodies and alloantigens. Int. J. Cancer 2004. 110: 51-60.